Publication | Closed Access

Stroke and Systemic Embolism Prevention in Patients with Atrial Fibrillation in Belgium: Comparative Cost Effectiveness of New Oral Anticoagulants and Warfarin

Comparative Cost EffectivenessThrombosisVenous ThrombosisStrokePublic HealthPlatelet AntagonistAtherosclerosisCardiologyNew Oral AnticoagulantsHealth PolicyAtrial FibrillationPulmonary EmbolismCardiovascular DiseaseIschemic StrokePatient SafetyCoagulopathyMedicineAnticoagulantAnesthesiology